Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa

被引:24
作者
Sivro, Aida [1 ,2 ]
McKinnon, Lyle R. [1 ,2 ]
Yende-Zuma, Nonhlanhla [1 ,3 ]
Gengiah, Santhana [1 ]
Samsunder, Natasha [1 ]
Karim, Salim S. Abdool [1 ,3 ,4 ]
Naidoo, Kogieleum [1 ,3 ]
机构
[1] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa
[2] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
[3] Univ KwaZulu Natal, Doris Duke Med Res Inst, MRC CAPRISA HIV TB Pathogenesis & Treatment Res U, Durban, South Africa
[4] Columbia Univ, Dept Epidemiol, New York, NY USA
基金
英国医学研究理事会; 比尔及梅琳达.盖茨基金会;
关键词
Tuberculosis; HIV; ART; cytokine; chemokine; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-PRODUCTION; SOLUBLE CD14; HIV; DISEASE; IP-10; ANTAGONIST; ACTIVATION; CLEARANCE; ALPHA;
D O I
10.1093/cid/cix357
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Immune correlates of tuberculosis (TB) risk in populations infected with human immunodeficiency virus (HIV) remain understudied, despite HIV being associated with a high burden of TB disease. Here we describe plasma cytokine correlates of TB recurrence in a well-characterized cohort of HIV-infected individuals on antiretroviral therapy (ART) with a history of prior TB cure. Methods. Study participants were drawn from a prospective cohort study initiated at the conclusion of a randomized clinical trial in which individuals presented with untreated HIV infection and active pulmonary TB. At baseline, ART was initiated, and TB successfully cured. Participants were screened for TB recurrence quarterly for up to 4 years. TB recurrent cases (n = 63) were matched to controls (n = 123) on sex, study arm assignment in the original trial, and month of enrollment with a subset of cases sampled longitudinally at several time-points. Results. Three cytokines were associated with increased rates of TB recurrence in univariate models: interleukin 6 (IL6) (odds ratio [OR] 2.66, 95% confidence interval [CI] 1.34-5.28, P=.005), IP10 (OR 4.62, 95% CI 1.69-12.65, P=.003), monokine induced by IFN-gamma (MIG) (OR 3.11, 95% CI 1.10-8.82, P=.034). Conversely, interferon beta (IFN beta) was associated with decreased TB risk (OR 0.34, 95% CI 0.13-0.87, P=.025). Following multivariate analyses adjusting for covariates IL6, interleukin 1 beta (IL1 beta), and interleukin 1R alpha (IL1R alpha) were associated with increased risk and IFN beta with decreased TB risk. Longitudinal analysis showed that levels of many TB-associated markers, including IL6, IP10, sCD14, and interferon gamma (IFN gamma) are reduced following TB treatment. Conclusion. These data show that TB recurrence, in HIV-infected individuals on ART is predicted by biomarkers of systemic inflammation, many of which are implicated in more rapid HIV disease progression.
引用
收藏
页码:819 / 826
页数:8
相关论文
共 40 条
[1]  
BARGETZI MJ, 1993, CANCER RES, V53, P4010
[2]   The spectrum of latent tuberculosis: rethinking the biology and intervention strategies [J].
Barry, Clifton E., III ;
Boshoff, Helena I. ;
Dartois, Veronique ;
Dick, Thomas ;
Ehrt, Sabine ;
Flynn, JoAnne ;
Schnappinger, Dirk ;
Wilkinson, Robert J. ;
Young, Douglas .
NATURE REVIEWS MICROBIOLOGY, 2009, 7 (12) :845-855
[3]   An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis [J].
Berry, Matthew P. R. ;
Graham, Christine M. ;
McNab, Finlay W. ;
Xu, Zhaohui ;
Bloch, Susannah A. A. ;
Oni, Tolu ;
Wilkinson, Katalin A. ;
Banchereau, Romain ;
Skinner, Jason ;
Wilkinson, Robert J. ;
Quinn, Charles ;
Blankenship, Derek ;
Dhawan, Ranju ;
Cush, John J. ;
Mejias, Asuncion ;
Ramilo, Octavio ;
Kon, Onn M. ;
Pascual, Virginia ;
Banchereau, Jacques ;
Chaussabel, Damien ;
O'Garra, Anne .
NATURE, 2010, 466 (7309) :973-U98
[4]   Mycobacterium tuberculosis and the host cell inflannmasome: a complex relationship [J].
Briken, Volker ;
Ahlbrand, Sarah E. ;
Shah, Swati .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2013, 3
[5]   Impact of early cART in the gut during acute HIV infection [J].
Deleage, Claire ;
Schuetz, Alexandra ;
Alvord, W. Gregory ;
Johnston, Leslie ;
Hao, Xing-Pei ;
Morcock, David R. ;
Rerknimitr, Rungsun ;
Fletcher, James L. K. ;
Puttamaswin, Suwanna ;
Phanuphak, Nittaya ;
Dewar, Robin ;
McCune, Joseph M. ;
Sereti, Irini ;
Robb, Merlin ;
Kim, Jerome H. ;
Schacker, Timothy W. ;
Hunt, Peter ;
Lifson, Jeffrey D. ;
Ananworanich, Jintanat ;
Estes, Jacob D. .
JCI INSIGHT, 2016, 1 (10)
[6]   The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis [J].
Gengiah, Tanuja N. ;
Holford, Nicholas H. G. ;
Botha, Julia H. ;
Gray, Andrew L. ;
Naidoo, Kogieleum ;
Karim, Salim S. Abdool .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) :689-695
[7]   Interferon-α Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers [J].
Hardy, Gareth A. D. ;
Sieg, Scott ;
Rodriguez, Benigno ;
Anthony, Donald ;
Asaad, Robert ;
Jiang, Wei ;
Mudd, Joseph ;
Schacker, Timothy ;
Funderburg, Nicholas T. ;
Pilch-Cooper, Heather A. ;
Debernardo, Robert ;
Rabin, Ronald L. ;
Lederman, Michael M. ;
Harding, Clifford V. .
PLOS ONE, 2013, 8 (02)
[8]   Efficacy of IP-10 as a biomarker for monitoring tuberculosis treatment [J].
Hong, Ji Young ;
Lee, Hye Jon ;
Kim, Song Yee ;
Chung, Kyung Soo ;
Kim, Eun Young ;
Jung, Ji Ye ;
Park, Moo Suk ;
Kim, Young Sam ;
Kim, Se Kyu ;
Chang, Joon ;
Cho, Sang-Nae ;
Kang, Young Ae .
JOURNAL OF INFECTION, 2014, 68 (03) :252-258
[9]   Inquiring into the differential action of interferons (IFNs):: an IFN-α2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-β [J].
Jaitin, DA ;
Roisman, LC ;
Jaks, E ;
Gavutis, M ;
Pichler, J ;
Van der Heyden, J ;
Uze, G ;
Schreiber, G .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (05) :1888-1897
[10]   IL-1β Promotes Antimicrobial Immunity in Macrophages by Regulating TNFR Signaling and Caspase-3 Activation [J].
Jayaraman, Pushpa ;
Sada-Ovalle, Isabel ;
Nishimura, Tomoyasu ;
Anderson, Ana C. ;
Kuchroo, Vijay K. ;
Remold, Heinz G. ;
Behar, Samuel M. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (08) :4196-4204